| |
 |
|
Class Information
Number: 514/43
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring
Description: Subject matter wherein the aglycone portion contains a nitrogen containing hetero ring.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
258 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3,242 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
535 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
500 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7608602 |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
Oct. 27, 2009 |
| 7608599 |
Antiviral phosphoramidates |
Oct. 27, 2009 |
| 7608597 |
Methods and compositions for treating hepatitis C virus |
Oct. 27, 2009 |
| 7605137 |
Combination therapy comprising cloretazine |
Oct. 20, 2009 |
| 7601701 |
Compounds for the treatment of tobacco dependence and withdrawal |
Oct. 13, 2009 |
| 7601735 |
Antiviral compounds |
Oct. 13, 2009 |
| 7589079 |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Sep. 15, 2009 |
| 7589068 |
Inhibitors of Akt activity |
Sep. 15, 2009 |
| 7582618 |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
Sep. 1, 2009 |
| 7582616 |
Nucleoside transport inhibitors |
Sep. 1, 2009 |
| 7579325 |
Drugs containing reduced of vitamin B.sub.2 |
Aug. 25, 2009 |
| 7576068 |
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
Aug. 18, 2009 |
| 7576069 |
2-polycyclic propynyl adenosine analogs having A2A agonist activity |
Aug. 18, 2009 |
| 7569555 |
Method for stimulating the immune, inflammatory or neuroprotective response |
Aug. 4, 2009 |
| 7563774 |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
Jul. 21, 2009 |
| 7560436 |
Methods of treating gastrointestinal inflammation |
Jul. 14, 2009 |
| 7560435 |
Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine) |
Jul. 14, 2009 |
| 7557092 |
Purinergic modulation of smell |
Jul. 7, 2009 |
| 7557093 |
Composition for promoting collagen production |
Jul. 7, 2009 |
| 7547684 |
5'-modified bicyclic nucleic acid analogs |
Jun. 16, 2009 |
| 7547680 |
Benzimidazole derivatives and medical uses thereof |
Jun. 16, 2009 |
| 7538094 |
Composition containing ribavirin and use thereof |
May. 26, 2009 |
| 7534771 |
Tricyclic-nucleoside prodrugs for treating viral infections |
May. 19, 2009 |
| 7528115 |
Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines |
May. 5, 2009 |
| 7524825 |
Tricyclic-nucleoside compounds for treating viral infections |
Apr. 28, 2009 |
| 7524831 |
Treatments for Flaviviridae virus infection |
Apr. 28, 2009 |
| 7510710 |
Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor |
Mar. 31, 2009 |
| 7462604 |
Hair growth promotor composition |
Dec. 9, 2008 |
| 7456155 |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
Nov. 25, 2008 |
| 7452870 |
Drug-eluting stents coated with P2Y.sub.12 receptor antagonist compound |
Nov. 18, 2008 |
| 7445794 |
Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors |
Nov. 4, 2008 |
| 7439271 |
Reduction of hair growth |
Oct. 21, 2008 |
| 7435724 |
Degradation-resistant mononucleoside phosphate compounds |
Oct. 14, 2008 |
| 7432248 |
Nucleoside derivatives for treating Hepatitis C virus infection |
Oct. 7, 2008 |
| 7429571 |
Therapeutic furopyrimidines and thienopyrimidines |
Sep. 30, 2008 |
| 7429569 |
Compositions and methods for the regulation of homocysteine levels within the body |
Sep. 30, 2008 |
| 7419963 |
Indole antiviral compositions and methods |
Sep. 2, 2008 |
| 7414031 |
5-nitro-nucleoside compounds for treating viral infections |
Aug. 19, 2008 |
| 7405204 |
Nucleoside compounds for treating viral infections |
Jul. 29, 2008 |
| 7399749 |
Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease |
Jul. 15, 2008 |
| 7399754 |
N.sup.2-quinoline or isoquinoline substituted purine derivatives |
Jul. 15, 2008 |
| 7396825 |
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
Jul. 8, 2008 |
| 7393839 |
Polymorphic antiviral nucleoside compounds |
Jul. 1, 2008 |
| 7378401 |
Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases |
May. 27, 2008 |
| 7365057 |
Modified 2' and 3'-nucleoside prodrugs for treating Flavivridae infections |
Apr. 29, 2008 |
| 7354906 |
Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human |
Apr. 8, 2008 |
| 7323453 |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds |
Jan. 29, 2008 |
| 7323451 |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Jan. 29, 2008 |
| 7323449 |
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Jan. 29, 2008 |
| 7319093 |
Antidiabetic 2-substituted-5'-O-(1-Boranotriphosphate) adenosine derivatives |
Jan. 15, 2008 |
|
|
|
